HUBEI PROVINCE, China--(BUSINESS WIRE)--Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTCBB:BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, will host a conference call on Wednesday, November 28, 2007, to review third quarter 2007 earnings results. The conference call is scheduled for 9:00 a.m., Eastern Time. To participate in the call, please dial:
